APOE: a risk factor for multiple disorders.

A. Myers,C. Nemeroff

DOI: https://doi.org/10.1097/JGP.0b013e318259b9a5

2012-07-01

Abstract:In the first study in this series, 3 longitudinal assessment of cognitive function was performed in 72 healthy elders, and the effects of both APOE genotype and family history of AD were determined. Subjects with a family history of AD had lower baseline scores in several tests of cognitive function; however, family history of AD was not associated with longitudinal cognitive decline. This suggests that family history establishes baselines of general cognition and cognitive reserve, but other factors may be necessary to initiate disease processes. In contrast, APOE alleles were not associated with baseline performance; however, upon follow-up, APOE E4 noncarriers showed improved cognitive performance. This suggests that APOE is perhaps involved in the synaptic processes of memory consolidation and neuronal plasticity, perhaps serving as a substrate for some of the wellknown protective effects of environmental variables such as education. In the second study in this series, 4 plasma concentrations of high-density lipoprotein (HDL), lowdensity lipoprotein, triglyceride, total cholesterol, and apoE, as well as cognitive performance and APOE genotypes, were measured. The study population was composed of 1,395 healthy cognitively normal individuals 65 years and older free of psychiatric illness from the Tone project, a community cohort from Tone town, Ibaraki, Japan, north of Tokyo. Overall cognitive scores were higher in APOE E4 negatives. Higher plasma levels of HDL were associated with better cognitive function in individuals without APOE E4 alleles. Individuals with higher plasma levels of apoE exhibited improved cognition, regardless of their E4 genotype. Scrutiny of both plasma levels of HDL and apoE, and APOE genotypes, revealed that the HDL differences with APOE genotype were mediated through apoE levels. The authors suggested that high peripheral HDL and ApoE could preserve cognition through apoE recycling, which would, in turn, reduce cholesterol accumulation. In the third article 5 in this series, APOE geno